METABOLIC PROFILING OF VALPROIC ACID IN PATIENTS USING NEGATIVE-ION CHEMICAL IONIZATION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY

A negative-ion chemical ionization gas chromatographic-mass spectrometric method for the determination of valproic acid (VPA) and fourteen of its metabolites in a single chromatographic run is reported. The assay features the use of four internal standards and is applicable to the analysis of small serum and urine volumes. A combination of pentafluorobenzyl and trimethylsilyl derivatization resulted in the [M-181]- ion as the base peak for all the metabolites measured. When these ions were monitored sensitivities in the low picogram levels were achieved. The VPA metabolite profile was determined in pediatric patients on VPA monotherapy and on combined VPA therapy with either carbamazepine or clobazam. The recently characterized diene metabolite, (E,E)-2,3′-diene-VPA, was found to be a major serum metabolite of VPA. In the patient groups taking VPA in combination with carbamazepine, the induction of ω and ω-1 pathways of VPA metabolism was apparent, while the levels of the β-oxidation products were significantly decreased. © 1990.